P&G Leverages Prilosec OTC, Oral Care Products To Increase Market Leads
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble's Prilosec OTC has garnered nearly a quarter share of the over-the-counter stomach remedy category
You may also be interested in...
Prilosec OTC Continues To Gain Share Amid Advertising, Supply Pressures
Procter & Gamble says sales of Prilosec OTC will face difficult year-over-year comparisons in the current quarter, indicating that growth for the heartburn drug may be slowing
Prilosec OTC Continues To Gain Share Amid Advertising, Supply Pressures
Procter & Gamble says sales of Prilosec OTC will face difficult year-over-year comparisons in the current quarter, indicating that growth for the heartburn drug may be slowing
Prilosec OTC Continues To Gain Share Amid Advertising, Supply Pressures
Procter & Gamble says sales of Prilosec OTC will face difficult year-over-year comparisons in the current quarter, indicating that growth for the heartburn drug may be slowing